Navegando por Palavras-chave "Patterns"

Agora exibindo 1 - 3 de 3
  • Nenhuma Miniatura disponível
    Item
    Somente Metadadados
    Iniquidades no acesso aos benefícios alimentação e refeição no Brasil: uma análise da Pesquisa de Orçamentos Familiares 2008-2009
    (Cadernos de Saúde Pública, 2016) Canella, Daniela Silva [UNIFESP]; Bortoletto Martins, Ana Paula; Bandoni, Daniel Henrique [UNIFESP]
    Food stamps and meal vouchers can determine workers' dietary choices. The study aimed to assess the coverage of these benefits in Brazil and their distribution according to the beneficiaries' socio-demographic and regional characteristics, using data from the Brazilian Household Budgets Survey, 2008-2009. Eligibility criteria were having an occupation and a private or government job, including domestic or temporary work in rural areas. Only 3.2% of eligible individuals reported receiving such benefits. Highest coverage rates were verified with the Southeast region, urban areas, male gender, employment in the private sector, and monthly earnings > five times the minimum wage. The mean monthly amount of such benefits was R$ 177.20 (US$ 100 at the 2009 exchange rate). After adjusting for other variables, the highest amounts were associated with male gender, higher salaries, the Northeast and Central regions, and employment in the public sector. This first analysis of the national coverage of food stamps and meal vouchers showed that a large share of Brazilian workers lack access or have unequal access to such benefits.
  • Nenhuma Miniatura disponível
    Item
    Somente Metadadados
    Use of benzodiazepines in obsessive-compulsive disorder
    (Lippincott Williams & Wilkins, 2016) Starcevic, Vladan; Berle, David; do Rosario, Maria Conceicao [UNIFESP]; Brakoulias, Vlasios; Ferrao, Ygor A.; Viswasam, Kirupamani; Shavitt, Roseli; Miguel, Euripedes; Fontenelle, Leonardo F.
    This study aimed to determine the frequency of benzodiazepine (BDZ) use in a large sample of patients with obsessive-compulsive disorder (OCD) and ascertain the type of BDZ used and the correlates and predictors of BDZ use in OCD. The sample consisted of 955 patients with OCD from a comprehensive, cross-sectional, multicentre study conducted by the Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders between 2003 and 2009. The rate of BDZ use over time in this OCD sample was 38.4%. Of individuals taking BDZs, 96.7% used them in combination with other medications, usually serotonin reuptake inhibitors. The most commonly used BDZ was clonazepam. Current age, current level of anxiety and number of additional medications for OCD taken over time significantly predicted BDZ use. This is the first study to comprehensively examine BDZ use in OCD patients, demonstrating that it is relatively common, despite recommendations from treatment guidelines. Use of BDZs in combination with several other medications over time and in patients with marked anxiety suggests that OCD patients taking BDZs may be more complex and more difficult to manage. This calls for further research and clarification of the role of BDZs in the treatment of OCD.
  • Nenhuma Miniatura disponível
    Item
    Somente Metadadados
    Use of benzodiazepines in obsessive-compulsive disorder
    (Lippincott Williams & Wilkins, 2016) Starcevic, Vladan; Berle, David; do Rosario, Maria Conceicao [UNIFESP]; Brakoulias, Vlasios; Ferrao, Ygor A.; Viswasam, Kirupamani; Shavitt, Roseli; Miguel, Euripedes; Fontenelle, Leonardo F.
    This study aimed to determine the frequency of benzodiazepine (BDZ) use in a large sample of patients with obsessive-compulsive disorder (OCD) and ascertain the type of BDZ used and the correlates and predictors of BDZ use in OCD. The sample consisted of 955 patients with OCD from a comprehensive, cross-sectional, multicentre study conducted by the Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders between 2003 and 2009. The rate of BDZ use over time in this OCD sample was 38.4%. Of individuals taking BDZs, 96.7% used them in combination with other medications, usually serotonin reuptake inhibitors. The most commonly used BDZ was clonazepam. Current age, current level of anxiety and number of additional medications for OCD taken over time significantly predicted BDZ use. This is the first study to comprehensively examine BDZ use in OCD patients, demonstrating that it is relatively common, despite recommendations from treatment guidelines. Use of BDZs in combination with several other medications over time and in patients with marked anxiety suggests that OCD patients taking BDZs may be more complex and more difficult to manage. This calls for further research and clarification of the role of BDZs in the treatment of OCD.